Rakuten Medical, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform, today announced the appointment of Mickey Mikitani as chief executive officer. Mr. Mikitani, a global business leader, will also continue in his role of chairman. In conjunction, former CEO Miguel Garcia-Guzman, Ph.D. will transition to serve as Rakuten Medical’s vice chairman and chief scientific officer to continue to build the company’s pipeline and drive innovation…click here to continue reading